|Bid||111.94 x 600|
|Ask||111.95 x 5200|
|Day's Range||111.42 - 112.14|
|52 Week Range||98.50 - 119.39|
|PE Ratio (TTM)||23.71|
|Dividend & Yield||3.22 (2.81%)|
|1y Target Est||N/A|
Pepsi's Indra Nooyi and Aetna's Mark Bertolini discuss millennials and social media.
Most of us have heard of Valeant Pharmaceuticals Intl Inc (NYSE:VRX). VRX stock infamously went from approximately $260 per share during the summer of 2015 to around $9 a share earlier this year. VRX stock has since rebounded, selling for $17 and change in July before falling back to today’s levels near $14.
New research suggests that investors do better when management shows some backbone.